Diazoxide for use in the treatment of a central nervous system (CNS) autoimmune demyelinating disease

Details for Australian Patent Application No. 2011203402 (hide)

Owner NEUROTEC PHARMA, S.L.

Inventors Pugliese, Marco; Mahy Gehenne, Josette-Nicole; Rodriguez Allue, Manuel; Espinosa Parrilla, Juan Francisco; Virgili Treserres, Noemi; Mancera Aroca, Pilar; Pasten Zamorano, Andrea

Agent Collison & Co

Pub. Number AU-A-2011203402

PCT Pub. Number WO2011/080344

Priority 10150027.0 04.01.10 EP

Filing date 4 January 2011

Wipo publication date 7 July 2011

International Classifications

A61K 31/549 - having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide

A61P 25/00 Drugs for disorders of the nervous system

Event Publications

26 July 2012 PCT application entered the National Phase

  PCT publication WO2011/080344 Priority application(s): WO2011/080344

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011203403-Photobioreactor in a closed environment for cultivating photosynthetic micro-organisms

2011203400-Administration route for a composition to protect an animal against Rhodococcus equi